Oral particle uptake and organ targeting drives the activity of amphotericin B nanoparticles.
Serrano DR, Lalatsa A, Dea-Ayuela MA, Bilbao-Ramos PE, Garrett NL, Moger J, Guarro J, Capilla J, Ballesteros MP, Schätzlein AG, Bolás F, Torrado JJ, Uchegbu IF.
Serrano DR, et al. Among authors: bilbao ramos pe.
Mol Pharm. 2015 Feb 2;12(2):420-31. doi: 10.1021/mp500527x. Epub 2015 Jan 15.
Mol Pharm. 2015.
PMID: 25558881
Free article.